USPTO serial 79303454
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey Halpern
Stacey Halpern Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software to measure, monitor, and manage medication adherence and support patients in improving medication adherence; downloadable software for use in measuring and monitoring medication adherence and patient compliance with drug regimens; downloadable software for use in tracking and managing medication; downloadable software for tracking, monitoring and managing medication; downloadable software for monitoring timestamp medication events; downloadable software to analyze food intake and medical symptoms; downloadable software to measure, track, monitor, and manage food intake and medical symptoms; downloadable programs for computers to measure, monitor, and manage medication adherence and support patients in improving medication adherence; downloadable programs for computers for use in measuring and monitoring medication adherence and patient compliance with drug regimens; downloadable programs for computers for use in tracking and managing medication; downloadable programs for computers for tracking, monitoring and managing medication; downloadable programs for computers for monitoring timestamp medication events; downloadable programs for computers to analyze food intake and medical symptoms; downloadable programs for computers to measure, track, monitor, and manage food intake and medical symptoms; downloadable computer application software for mobile telephones to measure, monitor, and manage medication adherence and support patients in improving medication adherence; downloadable computer application software for mobile telephones for use in measuring and monitoring medication adherence and patient compliance with drug regimens; downloadable computer application software for mobile telephones for use in tracking and managing medication; downloadable computer application software for mobile telephones for tracking, monitoring and managing medication; downloadable computer application software for mobile telephones for monitoring timestamp medication events; downloadable computer application software for mobile telephones to analyze food intake and medical symptoms; downloadable computer application software for mobile telephones to measure, track, monitor, and manage food intake and medical symptoms; downloadable software for tablet computers to measure, monitor, and manage medication adherence and support patients in improving medication adherence; downloadable software for tablet computers for use in measuring and monitoring medication adherence and patient compliance with drug regimens; downloadable software for tablet computers for use in tracking and managing medication; downloadable software for tablet computers for tracking, monitoring and managing medication; downloadable software for tablet computers for monitoring timestamp medication events; downloadable software for tablet computers to analyze of food intake and medical symptoms; downloadable software for tablet computers to measure, track, monitor, and manage food intake and medical symptoms; downloadable database management software for medication adherence; biometric access control systems namely, biometric identification apparatus; all of the foregoing excluding goods pertaining or related to wound care, wound care goods, wound care preparations, and wound care medications | ACTIVE | — |
| 021 | Pill boxes for personal use; personal dispensers for pills or capsules for domestic use; all of the foregoing excluding goods pertaining or related to wound care, wound care goods, wound care preparations, and wound care medications | ACTIVE | — |
| 035 | Electronic collection of data for business purposes in the field of medication adherence; data management services, namely, electronic data collection in the field of medication adherence for business purposes; statistical analysis and reporting for business purposes; commercial information agency services; systemization of information into computer databases; compilation of statistical information for business or commercial purposes; compilation of information into computer databases; all of the foregoing excluding services pertaining or related to wound care, wound care goods, wound care preparations, wound care medications, and wound care appliances, apparatus and devices | ACTIVE | — |
| 042 | Provision of scientific information in the field of medication adherence; creating of computer programs; software creation, namely, design and development of computer software; design, maintenance, development and updating of computer software; scientific analysis in the field of medication adherence; computer services for the analysis of data, namely, scientific analysis of a user's adherence, behavior, scheduling and reminders for taking medication; computer services for the analysis of data, namely, scientific analysis of a user's food intake; computer services for the analysis of data, namely, scientific analysis of a user's medical symptoms; all of the foregoing excluding services pertaining or related to wound care, wound care goods, wound care preparations, wound care medications, and wound care appliances, apparatus and devices | ACTIVE | — |
| 044 | Medical services; medical services, namely, consulting services in the field of medication adherence, food intake and individual's medical symptoms; providing health information; provision of pharmaceutical information relating to the dispensing of pharmaceuticals for medication adherence; medical information; provision of information relating to medicine; providing medical information; information services relating to health care; health advice and information services; medical care and analysis services relating to patient treatment; medical information services relating to veterinary pharmaceuticals regarding the dispensing of pharmaceuticals for animals; providing information relating to veterinary services; providing veterinary information; all of the foregoing excluding services pertaining or related to wound care, wound care goods, wound care preparations, wound care medications, and wound care appliances, apparatus and devices | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 27, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 10, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 10, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 24, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 24, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 24, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 22, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 22, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 17, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 30, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 30, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 30, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2024 | ALIE | ASSIGNED TO LIE | — |
| Apr 8, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 22, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 29, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 13, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 16, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 28, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 29, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 29, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 29, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 19, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 19, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 19, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 24, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 6, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 6, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 1, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 13, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 13, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 13, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 13, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 12, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 14, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 14, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 13, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 12, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 4, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 4, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |